Study shows an increased risk of breast cancer recurrence in postmenopausal patients with obesity and HR+ early-stage breast cancer treated with aromatase inhibitors.
Lawrence Faucette was dying from heart failure and ineligible for a traditional heart transplant when doctors at the University of Maryland School of Medicine offered the highly experimental surgery.